Ryuhjin Ahn, Alicia D D'Souza, Lawrence Long, Yufei Cui, Jennifer Gantchev, Gerard Baquer, Danielle Burgenske, Katrina K Bakken, Lauren L Ott, Brett L Carlson, Grace Zhou, Ishwar N Kohale, Charles A Whittaker, Heidi Temple, Tomer M Yaron-Barir, Jeffrey Wyckoff, Terry C Burns, Rachael A Vaubel, Cameron T Flower, Wei Huang, Ann Tuma, Jared L Johnson, Nathalie Y R Agar, Josie Ursini-Siegel, Sarkaria Jann, Forest M White
Dysregulation of intracellular signaling networks underpins cancer. Yet, resolving signaling networks within distinct or rare cell types in cancer in vivo has been unattainable. Here we develop INSIGHT by integrating cell sorting with mass spectrometry to enable quantitative phosphoproteomics and proteomics of discrete cell types from fixed tissues. Using INSIGHT, we map the signaling network within disseminating glioblastoma cells from patient-derived xenografts implanted in mice. Disseminating tumor cells undergo a proteome-wide shift from proliferative to mesenchymal, neural progenitor-like cell states. In parallel, signaling network and global kinase activity are rewired, transitioning from cell cycle-associated circuitries to those governing synaptic function, neuronal migration, and ion channel activity. Changes begin at the tumor margin and persist in distant brain parenchyma. Hornerin and phosphorylation of Ca²⁺-permeable GluA2 at Y876 were identified as mediators of glioblastoma progression. INSIGHT enables systems-level dissection of cell-type-specific signaling circuitries in vivo across wide range of biological systems.